摘要 |
<p>The invention relates to polymorphic Forms B, C, and D of methyl(+)-(S) -alpha-(2-chlorophenyl)-6, 7-dihydrothieno [3, 2-C]pyridine-5 (4H) acetate hydrobromide, to pharmaceutical compositions containing the same, and to the method of use thereof for inhibiting platelet aggregation.</p> |